Chemoinformaics analysis of acacetin-7-O- -L-rhamnopyranosyl-(1 6)- -Dglucopyranoside
| Molecular Weight | 578.523 | nRot | 8 |
| Heavy Atom Molecular Weight | 548.283 | nRig | 29 |
| Exact Molecular Weight | 578.164 | nRing | 5 |
| Solubility: LogS | -3.786 | nHRing | 3 |
| Solubility: LogP | 0.353 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 76.3218 |
| nHD | 7 | BPOL | 41.3802 |
| QED | 0.167 |
| Synth | 4.577 |
| Natural Product Likeliness | 2.036 |
| NR-PPAR-gamma | 0.937 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.991 |
| HIA | 0.952 |
| CACO-2 | -6.129 |
| MDCK | 0.000034 |
| BBB | 0.196 |
| PPB | 0.724897 |
| VDSS | 0.584 |
| FU | 0.134515 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.123 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.088 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.179 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.219 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.04 |
| CL | 1.66 |
| T12 | 0.202 |
| hERG | 0.164 |
| Ames | 0.623 |
| ROA | 0.033 |
| SkinSen | 0.046 |
| Carcinogencity | 0.842 |
| EI | 0.009 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.948 |
| Antiviral | Yes |
| Prediction | 0.886367 |